Elanco Animal Health (ELAN) vs Dr. Reddy's Laboratories (RDY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Elanco Animal Health (ELAN) has outperformed Dr. Reddy's Laboratories (RDY) over the past year, gaining 9.3% versus a loss of 12.5%. Over five years, RDY leads with a -7.1% price change compared with -31.3% for ELAN. Elanco Animal Health is the larger company by market cap ($11.26 billion vs $10.16 billion), about 1.1 times the size, while Dr. Reddy's Laboratories is growing revenue faster (+13.8% vs +6.2%).
On valuation, Elanco Animal Health trades at a lower forward P/E (17.5x vs 18.9x for Dr. Reddy's Laboratories). Dr. Reddy's Laboratories pays a dividend yielding 65.57%, while Elanco Animal Health does not currently pay one. Dr. Reddy's Laboratories converts more of its revenue into profit, with a net margin of 17.4% versus -4.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELAN | RDY |
|---|---|---|
| Share price | $22.54 | $12.20 |
| Market cap | $11.26B | $10.16B |
| 1-day change | +0.81% | -0.57% |
| YTD return | -1.19% | -12.61% |
| 1-year return | +9.34% | -12.54% |
| 5-year return | -31.28% | -7.06% |
| P/E ratio (TTM) | — | 27.73 |
| Forward P/E | 17.54 | 18.94 |
| EPS (TTM) | $-0.41 | $0.44 |
| Dividend yield | 0.00% | 65.57% |
| Annual dividend | $0.00 | $8.00 |
| Revenue (latest FY) | $4.71B | $3.81B |
| Revenue growth (YoY) | +6.22% | +13.76% |
| Net income (latest FY) | $-232.00M | $663.00M |
| Gross margin | 54.99% | 58.51% |
| Operating margin | — | 22.09% |
| Net margin | -4.92% | 17.40% |
| 52-week high | $27.98 | $15.67 |
| 52-week low | $19.40 | $11.36 |
| Distance from 52-week high | -19.44% | -22.14% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +37.53% | +8.36% |
| Average volume | 6.18M | 2.89M |
| Shares outstanding | 499.45M | 832.99M |
| Employees | 9,400 | 27,527 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELAN has outperformed RDY by 21.9 percentage points over the past year.
- Dr. Reddy's Laboratories offers a meaningfully higher dividend yield (65.57% vs 0.00%).
- Dr. Reddy's Laboratories is more profitable, keeping 17.4 cents of every revenue dollar as net income versus -4.9 cents for Elanco Animal Health.
- Dr. Reddy's Laboratories grew revenue faster in its latest fiscal year (+13.76% vs +6.22%).
About Elanco Animal Health
ELAN stock →Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark.
Health Care · Biotechnology: Pharmaceutical Preparations · 9,400 employees
About Dr. Reddy's Laboratories
RDY stock →Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 27,527 employees
ELAN vs RDY FAQ
Which is bigger, Elanco Animal Health or Dr. Reddy's Laboratories?
Elanco Animal Health (ELAN) is larger, with a market capitalization of $11.26B compared with $10.16B for Dr. Reddy's Laboratories (RDY).
Which stock has performed better over the past year, ELAN or RDY?
ELAN returned +9.34% over the past 12 months, compared with -12.54% for RDY (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Elanco Animal Health or Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories pays a dividend yielding 65.57%, while Elanco Animal Health does not currently pay a regular dividend.
Are Elanco Animal Health and Dr. Reddy's Laboratories in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.